Back
CRISPR Therapeutics AG Quote, Financials, Valuation and Earnings
Groundbreaking AI Developed In Small Georgia Town Destroys Wall Street
See the remarkable discovery.
Sell
50
CRSP
CRISPR Therapeutics AG
Last Price:
57.88
Seasonality Move:
-18.8%
7 Day Trial
ALL ACCESS PASS
$
7
Wall Street's Worst Nightmare: Small Town Trader's AI Edge
See the AI advantage for everyday Americans.CRISPR Therapeutics AG Price Quote
$57.88
+0.31 (+0.54%)
(Updated: July 26, 2024 at 6:55 PM ET)
CRISPR Therapeutics AG Key Stats
Sell
50
CRISPR Therapeutics AG (CRSP)
is a Sell
Day range:
$55.31 - $58.76
52-week range:
$37.55 - $91.10
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
2.35%
Volume:
1.1M
Avg. volume:
1.4M
1-year change:
3.84%
Market cap:
$4.9B
Revenue:
$370M
EPS:
$-2.69
How Much Does CRISPR Therapeutics AG Make?
Data Unavailable
Is CRISPR Therapeutics AG Growing As A Company?
Data Unavailable
CRISPR Therapeutics AG Stock Price Performance
-
Did CRISPR Therapeutics AG Stock Go Up Last Month?
CRISPR Therapeutics AG share price went up by 2.9% last month -
Did CRSP's Share Price Rise Over The Last Year?
CRSP share price rose by 3.84% over the past 1 year
What Is CRISPR Therapeutics AG 52-Week High & Low?
-
What Is CRISPR Therapeutics AG’s 52-Week High Share Price?
CRISPR Therapeutics AG has traded as high as $91.10 over the past 52 weeks -
What Is CRISPR Therapeutics AG’s 52-Week Low Share Price?
CRISPR Therapeutics AG has traded as low as $37.55 over the past 52 weeks
CRISPR Therapeutics AG Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy CRISPR Therapeutics AG?
-
How Much Debt Does CRISPR Therapeutics AG Have?
Total long term debt quarterly is $0 -
How Much Cash Does CRISPR Therapeutics AG Have?
Cash and short term investments quarterly total is $2.1B -
What Is CRISPR Therapeutics AG’s Book Value Per Share?
Book value per share is 24.56
Is CRISPR Therapeutics AG Cash Flow Positive?
-
What Is CRSP Cash Flow From Operations?
Cash flow from operations (TTM) is -$159.4M -
What Is CRISPR Therapeutics AG’s Cash Flow From Financing?
Cash flow from financing (TTM) is $363.2M -
What Is CRISPR Therapeutics AG’s Cash Flow From Investing?
Cash flow from investing (TTM) is $159M
CRISPR Therapeutics AG Return On Invested Capital
Data Unavailable
CRISPR Therapeutics AG Earnings Date & Stock Price
-
What Is CRISPR Therapeutics AG's Stock Price Today?
A single share of CRSP can be purchased today for 57.57 -
What Is CRISPR Therapeutics AG’s Stock Symbol?
CRISPR Therapeutics AG trades on the nasdaq under the ticker symbol: CRSP -
When Is CRISPR Therapeutics AG’s Next Earnings Date?
The next quarterly earnings date for CRISPR Therapeutics AG is scheduled on August 7, 2024 -
When Is CRSP's next ex-dividend date?
CRISPR Therapeutics AG's next ex-dividend date is July 27, 2024 -
How To Buy CRISPR Therapeutics AG Stock?
You can buy CRISPR Therapeutics AG shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
CRISPR Therapeutics AG Competitors
-
Who Are CRISPR Therapeutics AG's Competitors?
Below is a list of companies who compete with CRISPR Therapeutics AG or are related in some way:
CRISPR Therapeutics AG Dividend Yield
Data Unavailable
CRISPR Therapeutics AG Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | 2.38% |
| Revenue: | 0% | -98.1% |
Analyst Recommendations
| Buy Recommendations: | 11 |
|---|---|
| Hold Recommendations: | 11 |
| Sell Recommendations: | 2 |
| Price Target: | 86.57 |
| Upside from Last Price: | 50.37% |